7 Peptides Being Studied for Neuroprotective Properties
From anxiolytic sequences to brain-derived neurotrophic factor modulators, these 7 peptides are at the forefront of neuroprotection research. Strictly for research purposes only.
1. Selank — The Synthetic Tuftsin Analog
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. What distinguishes Selank in neuroprotection research is its dual mechanism — it modulates both the immune system (through its tuftsin-derived immunomodulatory activity) and the central nervous system (through effects on monoamine neurotransmitter metabolism and BDNF expression). Research published in several neuroscience journals has demonstrated that Selank increases BDNF mRNA expression in hippocampal neurons in rodent models, suggesting a mechanism through which it could support neuroplasticity and neuronal survival under stress conditions. Additionally, studies have examined its effects on the expression of genes related to the GABAergic system, finding modulation of GABA transporter and receptor subunit expression. The combination of immunomodulatory and neurotrophic properties makes Selank particularly interesting for research into neuroinflammatory conditions where both immune dysregulation and neuronal vulnerability are present simultaneously.
2. Semax — The ACTH Fragment with Nootropic Properties
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analog of the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics in Moscow and approved in Russia as a nootropic drug. For research purposes, Semax is significant because of its well-characterized neurotrophic effects in animal and cell culture models. Studies published in Neuroscience Letters and related journals have demonstrated that Semax upregulates the expression of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, as well as nerve growth factor (NGF), in various brain regions. The peptide has been shown to activate the Ras-MAP kinase signaling cascade and modulate gene expression patterns associated with neuronal survival and synaptic plasticity. Particularly relevant to neuroprotection research, Semax has been studied in ischemic brain injury models where it demonstrated neuroprotective effects associated with increased expression of neurotrophic factors and modulation of inflammatory gene expression. The peptide's ability to cross the blood-brain barrier via intranasal administration makes it an accessible research tool for studying central nervous system effects.
3. DSIP (Delta Sleep-Inducing Peptide) — The Stress-Response Modulator
Delta Sleep-Inducing Peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first isolated from the cerebral venous blood of rabbits during induced sleep in 1977. Despite its name suggesting a simple sleep-promoting function, DSIP's research profile is far more complex and interesting. The peptide has been studied for stress-protective properties that extend well beyond sleep modulation. Research has demonstrated DSIP's ability to normalize stress-induced disruptions in monoamine levels, modulate corticotropin and cortisol release under stress conditions, and exhibit antioxidant properties in neural tissue. What makes DSIP particularly intriguing for neuroprotection research is its apparent role as a stress-response modulator that promotes homeostasis rather than pushing a single pathway in one direction. In animal models of oxidative stress, DSIP has shown protective effects on neural tissue, reducing markers of oxidative damage and supporting cell viability. The peptide's natural presence in brain tissue and its multifunctional stress-modulatory profile position it as a research tool for understanding how endogenous peptide signals contribute to neural resilience.
4. Dihexa — The HGF/c-Met Pathway Activator
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a modified angiotensin IV analog developed by Dr. Joseph Harding's laboratory at Washington State University. The peptide made headlines in the research community when published work demonstrated its cognitive-enhancing effects in animal models at remarkably low concentrations — active at picomolar to nanomolar levels, making it orders of magnitude more potent than BDNF in certain assay systems. Dihexa works through the hepatocyte growth factor (HGF)/c-Met receptor system, which is involved in synaptogenesis, neuronal survival, and synaptic plasticity. Published research in the Journal of Pharmacology and Experimental Therapeutics showed that Dihexa facilitated formation of new synaptic connections and rescued cognitive deficits in animal models. For neuroprotection research, the HGF/c-Met pathway represents a relatively underexplored mechanism for promoting neuronal survival and connectivity. Dihexa provides researchers with a tool to probe this pathway's neuroprotective potential with the practical advantage of oral bioavailability in animal models.
5. N-Acetyl Semax Amidate — The Enhanced Semax Variant
N-Acetyl Semax Amidate (NASA) represents a chemically modified version of Semax designed to enhance stability and potentially extend duration of action. The modifications — acetylation of the N-terminus and amidation of the C-terminus — protect the peptide from exopeptidase degradation, which is the primary route of breakdown for linear peptides in biological systems. These modifications do not change the core pharmacological activity derived from the ACTH(4-10) sequence but rather extend the peptide's half-life by reducing enzymatic degradation. For research purposes, NASA allows investigation of Semax-like neurotrophic effects over extended time periods without the confounding variable of rapid metabolic degradation. Research interest in NASA has grown substantially as researchers seek longer-acting variants of established peptide tools for chronic administration studies. The enhanced stability also simplifies experimental protocols by reducing the frequency of peptide administration needed to maintain effective research concentrations in animal models.
6. P21 — The CNTF-Derived Neurogenic Peptide
P21 is a small peptide derived from the active region of Ciliary Neurotrophic Factor (CNTF), a neurotrophin that promotes neuronal survival and differentiation. The full CNTF protein does not cross the blood-brain barrier efficiently, limiting its utility as a research tool for studying central nervous system effects. P21 was designed to retain the neurogenic activity of the CNTF active site in a smaller, more brain-penetrant format. Research published by Dr. Khalid Iqbal's group at the New York State Institute for Basic Research demonstrated that P21 increased dentate gyrus neurogenesis and improved cognitive performance in multiple animal models. The peptide's mechanism involves inhibition of leukemia inhibitory factor (LIF) signaling, which in turn increases BDNF expression and promotes neurogenesis. For neuroprotection research, P21 provides a tool to study whether promoting adult neurogenesis can compensate for neuronal loss — a central question in neurodegenerative disease research. The peptide's small size and brain penetrance make it practically useful for chronic in vivo studies.
7. BPC-157 — The Gut-Brain Axis Peptide
While BPC-157 (Body Protection Compound 157) is most commonly associated with musculoskeletal tissue repair research, its neuroprotective properties are increasingly recognized and studied. The peptide, derived from a protein found in human gastric juice, has been examined in over 100 published studies including several focused on central nervous system effects. Research in animal models has demonstrated BPC-157's effects on dopaminergic, serotonergic, GABAergic, and opioid systems. Studies have examined its protective effects in models of traumatic brain injury, where it reduced brain edema and improved functional outcomes, and in models of neurotoxic damage, where it demonstrated neuroprotective properties. The peptide's interaction with the nitric oxide system — a key signaling molecule in both neuroprotection and neurodegeneration — provides a potential mechanism for its CNS effects. What makes BPC-157 particularly interesting for neuroprotection research is its gut-brain axis activity — as a gastric peptide with central nervous system effects, it represents the emerging understanding that gut-derived signals significantly influence brain function and survival, an area of intense scientific interest in 2026.
Research Disclaimer: All information on this page is provided for educational and research purposes only. Products discussed are intended for laboratory research use exclusively. They are not intended for human consumption, therapeutic use, or as dietary supplements. Always follow institutional guidelines and consult published peer-reviewed literature for research protocol development. Not for human consumption.